Share on

North America Animal / Veterinary Vaccines Market Research Report – Segmented By Type, Technology and Country (The U.S., Canada and Rest of North America) - Industry Analysis on Size, Share, Trends, COVID-19 Impact & Growth Forecast (2022 to 2027)

Published: January, 2022
ID: 61
Pages: 134
Formats: report pdf report excel report power bi report ppt

North American Animal / Veterinary Vaccines Market (2022 to 2027)

The North America Animal / Veterinary Vaccines Market is estimated to be worth USD 2.68 Billion by 2027 from USD 2.11 Billion in 2022, growing at a CAGR of 4.93% from 2022 to 2027.

The primary goals of veterinary vaccines are to improve the health of companion animals, cost-effectively increase livestock production, and prevent zoonotic disease transmission from both domestic and wild animals. The veterinary vaccine market in the North American region has shown significant growth in recent years, attributed to increasing husbandry practices and better managing farms. Furthermore, it marks the estimation of further growth in the market due to the advancement in biotechnological research.

The North America Animal / Veterinary Vaccines Market has undergone considerable progress during the past few years. The growing usage of continuous cell lines as a substrate and embracing the fermentor technology for antigen production. These vaccines are produced for administration by parenteral or oral routes depending on the vaccine characteristics. But it should be kept in mind that USDA APHIS regulations must be stringently followed for approval and distribution of veterinary biologics across the USA, the dominant economy in this region.

An increase in animal-borne diseases and awareness about veterinary healthcare is the primary factor in increasing the animal vaccine market growth globally. The number of pet owners worldwide, especially in North America, has gone up, predicted to help the market gain speed. Increasing investments by leading market players, various government agencies and animal associations, continuous innovations, and raising awareness against antimicrobials drive the vaccine producers to invest significantly in developing new products.

The Growing prevalence of animal diseases, rising incidences of zoonotic diseases in humans, increasing investments by leading players, various government agencies, and animal associations; continuous innovations, raising awareness against the use of antimicrobials is driving the vaccine producers to invest significantly into the development of new products.

However, rising maintenance costs for the storage of vaccines and increasing adoption of a vegetarian diet in major economies due to the increased risk of obesity and other chronic diseases are key restraints.

Impact of COVID-19 on the North American veterinary vaccines market:

COVID-19 has disrupted the supply chain of products all over the world. The risk of disease transmission from animals to humans has come to light in the last few months owing to the worldwide spread of COVID-19. Individuals and governments are expected to focus on domestic and wild animals' health in the future, thus increasing the market.

This research report on the North American veterinary vaccines market has been segmented and sub-segmented into the following categories:

By Type: 

  • Livestock Vaccines
    • Bovine
    • Porcine
    • Ovine
    • Poultry
    • Equine  
  • Companion Vaccines
    • Feline Vaccines
    • Canine Vaccines

By Technology: 

  • Live Attenuated Vaccines
  • Inactivated Vaccines
  • Recombinant Vaccines
  • Toxoid Vaccines
  • Subunit Vaccines
  • DNA Vaccines
  • Conjugate Vaccines

Based on technology, the canine vaccines segment accounted for a slightly larger share (in terms of revenue) than the feline vaccines segment due to the higher average cost allied with canine vaccination. Similarly, the bovine vaccines sub-segment accounted for the largest share (in terms of revenue), followed by porcine.

By Country: 

  • The U.S.
  • Canada
  • Rest of North America

Geographically, in North America, the U.S. veterinary vaccines market is forecasted to account for the most significant share from 2022 to 2027, owing to the rapid adoption of technological advancements. In addition, ongoing research on developing innovative drugs and vaccines with modern techniques promotes the market's growth rate in the United States.

The Canadian Veterinary Vaccines Market is estimated to have a promising CAGR during the forecast period. Rising concern towards animal health and shifting trends towards providing nutritious food to the animals are primarily promoting the Canadian market.

KEY MARKET PLAYERS:

A few of the prominent companies operating in the North American Veterinary / Animal Healthcare Market profiled in this report are Bayer HealthCare AG, Bioniche Animal Health Canada, Sanofi Animal Health Inc., Biogenesis Bago SA, Heska Corporation, Indian Immunologicals Ltd., Boehringer Ingelheim GmbH, Zoetis, Novartis Animal Health Inc., Merck & Co Inc., and Protein Sciences.

Please wait. . . . Your request is being processed

Related Reports

Access the study in MULTIPLE FORMATS
Purchase options starting from $ 2000

Didn’t find what you’re looking for?
TALK TO OUR ANALYST TEAM

Need something within your budget?
NO WORRIES! WE GOT YOU COVERED!

REACH OUT TO US

Call us on: +1 888 702 9696 (U.S Toll Free)

Write to us: sales@marketdataforecast.com

Click for Request Sample